Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation

• US 8,440,404 B2
• Filed: 03/03/2005
• Issued: 05/14/2013
• Est. Priority Date: 03/08/2004
• Status: Expired due to Fees

• Current Assignee: Takara Bio Usa, Inc. (Ningbo Junsheng Investment Group Co., Ltd.)
• Original Assignee: Rubicon Genomics, Inc (Ningbo Junsheng Investment Group Co., Ltd.)
• Inventors: Makarov, Vladimir L., Kamberov, Emmanuel, Sun, Tong, Pinter, Jonathon H., Tarrier, Brendan J., Bruening, Eric E., Kurihara, Takao, Tesmer, Tim, M'Mwirichia, Joseph
• Primary Examiner(s): DUNSTON, JENNIFER ANN
• Application Number:
  US11/071,864
• Publication Number:
  US 20050202490A1
• Time in Patent Office: 2,994 Days
• Field of Search: None
• US Class Current: 435/6.11
• CPC Class Codes: C12N 15/1072 Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6855 Ligating adaptors
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 2521/331 Methylation site specific nuclease
• CPC Class Codes: C12Q 2523/125 Bisulfite(s)
• CPC Class Codes: C12Q 2525/191 incorporating an adaptor
• CPC Class Codes: C12Q 2525/301 Hairpin oligonucleotides

Abstract

The present invention regards a variety of methods and compositions for obtaining epigenetic information, such as DNA methylation patterns, through the preparation, amplification and analysis of Methylome libraries. In particular, the method employs preparation of a DNA molecule by digesting the DNA molecule with at least one methylation-sensitive restriction enzyme; incorporating a nucleic acid molecule into at least some of the digested DNA molecules by either (1) incorporating at least one primer from a plurality of primers that have a 5′ constant sequence and a 3′ variable sequence, wherein the primers are substantially non-self-complementary and substantially non-complementary to other primers in the plurality; or (2) incorporating an oligonucleotide having an inverted repeat and a loop under conditions wherein the oligonucleotide becomes blunt-end ligated to one strand of the digested DNA molecule, followed by polymerization from a 3′ hydroxyl group present in a nick in the oligonucleotide-linked molecule; and amplifying one or more of the DNA molecules.

Claims

1. A method of preparing a DNA molecule, comprising:

(a) providing a DNA molecule;

(b) digesting the DNA molecule with at least one methylation-sensitive restriction enzyme and, optionally, an additional nuclease, to provide digested DNA molecules;

(c) incorporating a nucleic acid molecule into at least some of the digested DNA molecules to provide first modified DNA molecules, by;

incorporating at least one primer from a plurality of primers, said primers comprising a 5′

constant sequence and a 3′

variable sequence that is substantially non-self-complementary and substantially non-complementary to other primers in the plurality, wherein the sequence of the constant and variable regions consists essentially of only two types of non-complementary nucleotides selected from the group consisting of adenines and guanines;

adenines and cytosines;

guanines and thymidines; and

cytosines and thymidines, such that the primers of the population will not cross-hybridize or self-hybridize under conditions employed in step d); and

(d) amplifying one or more of the first modified DNA molecules to provide amplified first modified DNA molecules.

2. The method of claim 1, further comprising analyzing at least part of the sequence of an amplified modified DNA molecule.

3. The method of claim 2, wherein the analyzing step comprises sequencing, quantitative real-time polymerase chain reaction, ligation chain reaction, ligation-mediated polymerase chain reaction, probe hybridization, probe amplification, microarray hybridization, restriction enzyme digestion, or a combination thereof.

4. The method of claim 1, wherein the DNA molecule that is provided is from a body fluid or tissue.

5. The method of claim 4, wherein the body fluid comprises blood, serum, urine, cerebrospinal fluid, nipple aspirate, sweat, or saliva.

6. The method of claim 4, wherein the tissue comprises biopsy, surgical sample, or cheek scrapings.

7. The method of claim 1, wherein the DNA molecule that is provided is from a sample of an individual that has a medical condition.

8. The method of claim 7, wherein the medical condition is cancer.

9. The method of claim 1, wherein the methylation-sensitive restriction enzyme has a 4-5 base pair recognition site that comprises at least one CpG dinucleotide.

10. The method of claim 1, wherein the methylation-sensitive restriction enzyme is Aci I, Bst UI, Hha I, HinP1, Hpa II, Hpy 99I, Ava I, Bce AI, Bsa HI, Bsi E1, Hga I, or a mixture thereof.

11. The method of claim 1, wherein the optional additional nuclease comprises a restriction endonuclease.

12. The method of claim 1, wherein the optional additional nuclease comprises DNAase I.

13. The method of claim 1, wherein the incorporating step is further defined as:

fragmenting and generating single stranded nucleic acid molecules from at least some of the digested DNA molecules by heating;

subjecting the single stranded nucleic acid molecules to a plurality of primers to form a single stranded nucleic acid molecule/primer mixture, wherein the primers comprise nucleic acid sequence that is substantially non-self-complementary and substantially non-complementary to other primers in the plurality and wherein the primers comprise a constant nucleic acid sequence and a variable nucleic acid sequence, wherein the sequence of the constant and variable regions consists essentially of only two types of non-complementary nucleotides selected from the group consisting of adenines and guanines;

adenines and cytosines;

guanines and thymidines; and

cytosines and thymidines, such that the primers of the population will not cross-hybridize or self-hybridize; and

subjecting said single stranded nucleic acid molecule/primer mixture to a polymerase to generate a plurality of molecules comprising the constant nucleic acid sequence at each end.

14. The method of claim 1, wherein the amplifying step comprises polymerase chain reaction.

15. The method of claim 1, further defined as determining the methylation status of at least part of the provided DNA molecule.

16. The method of claim 1, further defined as performing the method with a provided molecule from a sample of an individual with a medical condition in comparison to performing the method with a control.

17. The method of claim 16, wherein the medical condition is cancer.

18. The method of claim 1, wherein the provided DNA molecule comprises a promoter, a CpG island, or both.

19. The method of claim 1, wherein the amplifying step utilizes a primer that is complementary to the incorporated nucleic acid molecule.

20. The method of claim 1, wherein the constant and variable regions consist essentially of guanines, adenines, or both.

21. The method of claim 1, wherein the constant and variable regions consist essentially of cytosines, thymidines, or both.

22. The method of claim 1, wherein the constant and variable regions consist essentially of adenines, cytosines, or both.

23. The method of claim 1, wherein the constant and variable regions consist essentially of guanines, thymidines, or both.

24. The method of claim 1, wherein the primer is further comprised of 0 to about 3 random bases at its distal 3′

end.

25. The method of claim 1, wherein the constant region and the variable region each consist of only two non-complementary nucleotides and wherein the polynucleotide comprises 0, 1, 2, or 3 random bases at its 3′

end.

26. A method of preparing a DNA molecule, comprising:

(a) providing a DNA molecule;

(b) digesting the molecule with one or more methylation-specific endonucleases to provide DNA fragments;

(c) incorporating a nucleic acid molecule into the DNA fragments to provide first modified DNA molecules, by a method comprising;

incorporating at least one primer from a plurality of primers, said primer comprising a 5′

constant sequence and a 3′

variable sequence that is substantially non-self-complementary and substantially non-complementary to other primers in the plurality, and further wherein the sequence of the constant and variable regions consists essentially of only two types of non-complementary nucleotides selected from the group consisting of adenines and guanines;

adenines and cytosines;

guanines and thymidines; and

cytosines and thymidines, such that the primers of the population will not cross-hybridize or self-hybridize under conditions employed in step d); and

(d) amplifying at least one first modified DNA molecule to provide amplified DNA molecules.

27. The method of claim 26, wherein the amplifying step utilizes a primer that is complementary to the incorporated nucleic acid molecule.

28. The method of claim 26, wherein the method further comprises the step of analyzing at least one of the amplified DNA molecules to determine the methylation status of the provided DNA.

29. The method of claim 26, wherein the methylation-specific endonuclease is McrBc.

30. The method of claim 26, wherein the amplifying step comprises polymerase chain reaction.

31. A method of preparing a DNA molecule, comprising:

(a) providing a bisulfite-converted DNA molecule;

(b) incorporating a nucleic acid molecule into at least some of the digested DNA molecules to provide first modified DNA molecules, by incorporating at least one primer from a plurality of primers, said primers comprising a 5′

constant sequence and a 3′

variable sequence that is substantially non-self-complementary and substantially non-complementary to other primers in the plurality, wherein the sequence of the constant and variable regions consists essentially of only two types of non-complementary nucleotides selected from the group consisting of adenines and guanines;

adenines and cytosines;

guanines and thymidines; and

cytosines and thymidines, such that the primers of the population will not cross-hybridize or self-hybridize under conditions employed in step d); and

(c) amplifying one or more of the first modified DNA molecules to provide amplified first modified DNA molecules.

32. The method of claim 31, wherein the constant and variable regions consist essentially of guanines, adenines, or both.

33. The method of claim 31, wherein the constant and variable regions consist essentially of cytosines, thymidines, or both.

34. The method of claim 31, wherein the constant and variable regions consist essentially of adenines, cytosines, or both.

35. The method of claim 31, wherein the constant and variable regions consist essentially of guanines, thymidines, or both.

36. The method of claim 31, wherein the primer is further comprised of 0 to about 3 random bases at its distal 3′

end.

37. The method of claim 31, wherein the constant region and the variable region each consist of only two non-complementary nucleotides wherein the polynucleotide comprises 0, 1, 2, or 3 random bases at its 3′

end.